NASDAQ:NWBO - Nasdaq -
0.57
-0.13 (-18.57%)
The current stock price of NWBO is 0.57 null. In the past month the price increased by 1.79%. In the past year, price decreased by -87.02%.
Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.
Northwest Bioth New
4800 MONTGOMERY LANE SUITE 800
BETHESDA MD 20814
CEO: Linda F. Powers
Phone: 240-497-9024
The current stock price of NWBO is 0.57 null. The price decreased by -18.57% in the last trading session.
The exchange symbol of Northwest Bioth New is NWBO and it is listed on the Nasdaq exchange.
NWBO stock is listed on the Nasdaq exchange.
Northwest Bioth New (NWBO) has a market capitalization of 109.33M null. This makes NWBO a Micro Cap stock.
Northwest Bioth New (NWBO) has a support level at 0.52 and a resistance level at 0.61. Check the full technical report for a detailed analysis of NWBO support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NWBO does not pay a dividend.
Northwest Bioth New (NWBO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.77).
The outstanding short interest for Northwest Bioth New (NWBO) is 33.55% of its float. Check the ownership tab for more information on the NWBO short interest.
ChartMill assigns a technical rating of 5 / 10 to NWBO. When comparing the yearly performance of all stocks, NWBO is a bad performer in the overall market: 91.35% of all stocks are doing better.
Over the last trailing twelve months NWBO reported a non-GAAP Earnings per Share(EPS) of -0.77. The EPS increased by 32.95% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 100.73% | ||
ROA | -168.29% | ||
ROE | 0% | ||
Debt/Equity | 0 |